Neue Suche | Kongressdetail
mail
Druckansicht
 
 

4th Tumor Myeloid Targeting Therapies Summit 2024

Evvnt Promotion / evvnt
Archiv
-
11.06.2024 - 13.06.2024  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
 
Kongressthemen
The landscape of innate immune cells is rapidly advancing towards clinical applications. Multiple published studies in the last year repeatedly affirm that targeting myeloid cells rather than the cancer cells themselves can shrink tumors, further providing confidence in their potential as a clinically effective therapeutic.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/2219781-3?pid=4832

Speakers: Akshata Udyavar, Senior Director, Actym Therapeutics, Peter Ellmark, CSO, Alligator Bioscience, Stephanie Casey Parks, Principal Scientist, Amgen, and more
 

Anfragen und Anmeldung:

https://go.evvnt.com/2219781-2?pid=4832
Herr Luke Kelly
 
Kategorien
Onkologie
Sprache
Englisch
Kongressgebühr
USD 2199.00 - USD 5097.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Ärztekammer für WienAlumni Club Medizinische Universität WienOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Österreichische Akademie der ÄrztenewTreeCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioSwiss Tropical and Public Health InstituteEuropean Public Health Association (EUPHA)